ERIN ANDERSON: Open Payments
NPI 1538264817 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,977 in 80 payments from 34 companies in 2025. Trend: 2023 $1,430 · 2024 $2,063 · 2025 $1,977
Food & beverage: $1,757Education: $220
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $173 |
| Astellas Pharma US Inc | 4 | $170 |
| Daiichi Sankyo Inc. | 10 | $152 |
| AstraZeneca Pharmaceuticals LP | 5 | $150 |
| ABBVIE INC. | 6 | $115 |
| SEAGEN INC. | 1 | $95 |
| ARRAY BIOPHARMA INC | 7 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| GENZYME CORPORATION | 2 | $78 |
| SOBI, INC | 3 | $77 |
Products named: MONJUVI, Vanflyta, TAGRISSO, Vonjo, KEYTRUDA, OJJAARA, VENCLEXTA, LORBRENA.
Industry payments across CA — which companies pay providers there.
